BouNDless: An active-controlled, randomised, double-blind, double-dummy trial of continuous subcutaneous infusion of levodopa/carbidopa with ND0612 in patients with Parkinson's disease. (October 2020) - Rascol, O.; Poewe, W.; Stocchi, F.; Yardeni, T.; Barak, S. Leibman; Adar, L.; Rosenfeld, O.; Olanow, C.W.